Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors
Natalia A. Kuzmina(Galveston College), Alexander Bukreyev(Galveston College), Philipp A. Ilinykh(Houston Methodist), Pavlo Gilchuk(AstraZeneca (Japan)), James E. Crowe(Vanderbilt University Medical Center), Patrick Younan(Galveston College), Rodrigo I. Santos(Universidade de São Paulo), Andrew I. Flyak(Vanderbilt University), Palaniappan Ramanathan(The University of Texas Medical Branch at Galveston), Ndongala Michel Lubaki(Galveston College), Kai Huang(Galveston College)
Cited by 99
Related Papers
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543
Taxonomy of the order Mononegavirales: update 2016
|Archives of Virology|2016|506